Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy
Clinical trial NCT04985201 · UNKNOWN
Trial details
- NCT number
- NCT04985201
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2022-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.